» Articles » PMID: 38473374

Association of Social Determinants with Patient-Reported Outcomes in Patients with Cancer

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2024 Mar 13
PMID 38473374
Authors
Affiliations
Soon will be listed here.
Abstract

Patient-reported outcome (PRO) scores have been utilized more frequently, but the relationship of PRO scores to determinants of health and social inequities has not been widely studied. Our goal was to determine the association of PRO scores with social determinants. All patients with a new cancer diagnosis who completed a PRO survey from 2020 to 2022 were included. The PRO survey recorded scores for depression, fatigue, pain interference and physical function. Higher depression, fatigue and pain scores indicated more distress. Higher physical condition scores indicated improved functionality. A total of 1090 patients were included. Married patients had significantly better individual PRO scores for each domain. Patients who were able to use the online portal to complete their survey also had better individual scores. Male patients and non-White patients had worse pain scores than female and White patients, respectively. Patients with prostate cancer had the best scores while patients with head and neck and lung cancer had the worst scores. PRO scores varied by cancer disease site and stage. Social support may act in combination with specific patient/tumor factors to influence PRO scores. These findings present opportunities to address patient support at institutional levels.

Citing Articles

Predictors of Concordance between Patient-Reported and Provider-Documented Symptoms in the Context of Cancer and Multimorbidity.

Gilbertson-White S, Albashayreh A, Ji Y, Bandyopadhyay A, Zeinali N, Cherwin C Appl Clin Inform. 2024; 15(5):1130-1139.

PMID: 39721578 PMC: 11669442. DOI: 10.1055/s-0044-1791820.


Risk of significant functional impairment across cancer diagnosis and care continuum.

Flores A, Shah M, Bedjeti K, Franklin P, Peipert J, Garcia S Cancer. 2024; 131(1):e35571.

PMID: 39297349 PMC: 11694161. DOI: 10.1002/cncr.35571.

References
1.
Lara Jr P, Higdon R, Lim N, Kwan K, Tanaka M, Lau D . Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001; 19(6):1728-33. DOI: 10.1200/JCO.2001.19.6.1728. View

2.
Norouzinia R, Aghabarari M, Shiri M, Karimi M, Samami E . Communication Barriers Perceived by Nurses and Patients. Glob J Health Sci. 2016; 8(6):65-74. PMC: 4954910. DOI: 10.5539/gjhs.v8n6p65. View

3.
Lee J, Longcoy L, Tai C . Symptom Distress and Quality of Life in Women With Newly Diagnosed Ovarian Cancer Undergoing Chemotherapy: A Longitudinal Approach. Clin J Oncol Nurs. 2022; 26(6):643-650. DOI: 10.1188/22.CJON.643-650. View

4.
Okereke I, Westra J, Tyler D, Klimberg S, Jupiter D, Venkatesan R . Disparities in esophageal cancer care based on race: a National Cancer Database analysis. Dis Esophagus. 2021; 35(6). DOI: 10.1093/dote/doab083. View

5.
Sun E, Alvarez C, Callahan L, Sheikh S . The Disparities in Patient Portal Use Among Patients With Rheumatic and Musculoskeletal Diseases: Retrospective Cross-sectional Study. J Med Internet Res. 2022; 24(8):e38802. PMC: 9439379. DOI: 10.2196/38802. View